(Q33977664)

30 July 2017

Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials (English)

1 reference

multicenter clinical trial

30 July 2017

0 references

cystic fibrosis

0 references

author name string

Thomas A Standaert

1

1 reference

30 July 2017

Louis Boitano

2

1 reference

30 July 2017

Julia Emerson

3

1 reference

30 July 2017

Laura J H Milgram

4

1 reference

30 July 2017

Michael W Konstan

5

1 reference

30 July 2017

Janice Hunter

6

1 reference

30 July 2017

Pierre-Yves Berclaz

7

1 reference

30 July 2017

Lois Brass

8

1 reference

30 July 2017

Pamela L Zeitlin

9

1 reference

30 July 2017

Keith Hammond

10

1 reference

30 July 2017

Zoe Davies

11

1 reference

30 July 2017

Carla Foy

12

1 reference

30 July 2017

Peadar G Noone

13

1 reference

30 July 2017

Michael R Knowles

14

1 reference

30 July 2017

1 May 2004

1 reference

30 July 2017

Pediatric Pulmonology

1 reference

30 July 2017

37

1 reference

30 July 2017

5

1 reference

30 July 2017

385-392

1 reference

Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

Conventional and modified nasal potential-difference measurement in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

Effect of oral digoxin, topical ouabain and salbutamol on transepithelial nasal potential difference in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10448

21 January 2018

Identifiers

DOI

10.1002/PPUL.10448

1 reference

30 July 2017

1 reference